Hirohito Fujikawa

1.2k total citations
54 papers, 780 citations indexed

About

Hirohito Fujikawa is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Hirohito Fujikawa has authored 54 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 30 papers in Surgery and 14 papers in Oncology. Recurrent topics in Hirohito Fujikawa's work include Gastric Cancer Management and Outcomes (40 papers), Metastasis and carcinoma case studies (23 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Hirohito Fujikawa is often cited by papers focused on Gastric Cancer Management and Outcomes (40 papers), Metastasis and carcinoma case studies (23 papers) and Gastrointestinal Tumor Research and Treatment (11 papers). Hirohito Fujikawa collaborates with scholars based in Japan, United States and United Kingdom. Hirohito Fujikawa's co-authors include Munetaka Masuda, Yasushi Rino, Takaki Yoshikawa, Takashi Ogata, Haruhiko Cho, Toru Aoyama, Takanobu Yamada, Tsutomu Hayashi, Takashi Oshima and Norio Yukawa and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Hirohito Fujikawa

48 papers receiving 772 citations

Peers

Hirohito Fujikawa
Hirohito Fujikawa
Citations per year, relative to Hirohito Fujikawa Hirohito Fujikawa (= 1×) peers Tatsuto Nishigori

Countries citing papers authored by Hirohito Fujikawa

Since Specialization
Citations

This map shows the geographic impact of Hirohito Fujikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirohito Fujikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirohito Fujikawa more than expected).

Fields of papers citing papers by Hirohito Fujikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirohito Fujikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirohito Fujikawa. The network helps show where Hirohito Fujikawa may publish in the future.

Co-authorship network of co-authors of Hirohito Fujikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hirohito Fujikawa. A scholar is included among the top collaborators of Hirohito Fujikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirohito Fujikawa. Hirohito Fujikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mano, Yasunobu, Yuka Igarashi, KEISUKE KOMORI, et al.. (2025). Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer. Frontiers in Immunology. 16. 1521278–1521278.
2.
KOMORI, KEISUKE, Kazuki Kano, Yukio Maezawa, et al.. (2023). Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer. Anticancer Research. 43(6). 2865–2871.
4.
KOMORI, KEISUKE, Kazuki Kano, Takanobu Yamada, et al.. (2022). Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study. Anticancer Research. 42(5). 2719–2725. 2 indexed citations
5.
Fujikawa, Hirohito, KEISUKE KOMORI, Kazuki Kano, et al.. (2021). Prognostic Factors for Gastric Cancer Patients With One Stage IV Factor who Underwent Conversion Surgery. Anticancer Research. 41(2). 1005–1012. 3 indexed citations
6.
Kono, Kenichi, Kosaku Mimura, Y. Yoshimoto, et al.. (2021). 1393P Phase I/II clinical trial of combination of anti-PD-1 mAb, nivolumab with radiotherapy for unresectable and recurrent gastric cancer who failed to standard chemotherapy. Annals of Oncology. 32. S1053–S1054. 1 indexed citations
7.
Kano, Kazuki, Takanobu Yamada, Kouji Yamamoto, et al.. (2021). The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer. Annals of Surgical Oncology. 28(8). 4530–4539. 24 indexed citations
8.
Kano, Kazuki, Takanobu Yamada, KEISUKE KOMORI, et al.. (2021). The Prognostic Value of Lymph Node Ratio in Locally Advanced Esophageal Cancer Patients Who Received Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 28(13). 8464–8472. 11 indexed citations
9.
Yamada, Takanobu, Tsutomu Hayashi, KEISUKE KOMORI, et al.. (2020). Impact of the Neutrophil-to-Lymphocyte Ratio on the Survival of Patients with Gastric Cancer Treated with Nivolumab Monotherapy. Targeted Oncology. 15(3). 317–325. 23 indexed citations
10.
Fujikawa, Hirohito, Kazuki Kano, Toru Aoyama, et al.. (2020). The Clinical Significance of Lymphovascular Invasion in Gastric Cancer. In Vivo. 34(3). 1533–1539. 31 indexed citations
11.
Segami, Kenki, Toru Aoyama, Kazuki Kano, et al.. (2017). Risk factors for severe weight loss at 1 month after gastrectomy for gastric cancer. Asian Journal of Surgery. 41(4). 349–355. 19 indexed citations
12.
Yamada, Takanobu, Akira Tsuburaya, Tsutomu Hayashi, et al.. (2016). Usefulness of Surgical Apgar Score on Predicting Survival After Surgery for Gastric Cancer. Annals of Surgical Oncology. 23(S5). 757–763. 9 indexed citations
13.
Aoyama, Toru, Tsutomu Sato, Kenki Segami, et al.. (2016). Risk Factors for the Loss of Lean Body Mass After Gastrectomy for Gastric Cancer. Annals of Surgical Oncology. 23(6). 1963–1970. 35 indexed citations
14.
Fujikawa, Hirohito, Kentaro Sakamaki, Tsutomu Hayashi, et al.. (2015). A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment. Annals of Surgical Oncology. 22(7). 2317–2322. 3 indexed citations
15.
Aoyama, Toru, Takaki Yoshikawa, Satoshi Morita, et al.. (2014). Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study. BMC Cancer. 14(1). 155–155. 4 indexed citations
16.
Aoyama, Toru, Takaki Yoshikawa, Tsutomu Hayashi, et al.. (2014). Randomized Comparison of Surgical Stress and the Nutritional Status Between Laparoscopy-Assisted and Open Distal Gastrectomy for Gastric Cancer. Annals of Surgical Oncology. 21(6). 1983–1990. 36 indexed citations
17.
Yamada, Takanobu, Tsutomu Hayashi, Toru Aoyama, et al.. (2014). Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective study. BMC Surgery. 14(1). 41–41. 33 indexed citations
18.
Aoyama, Toru, Tsutomu Hayashi, Hirohito Fujikawa, et al.. (2013). [Effect of enteral nutrition enriched with eicosapentaenoic acid on body weight loss and compliance with S-1 adjuvant chemotherapy after gastric cancer surgery].. PubMed. 40(12). 2289–91. 5 indexed citations
19.
Yoshikawa, Takaki, Tsutomu Hayashi, Toru Aoyama, et al.. (2012). Laparoscopic esophagojejunostomy using the EndoStitch and a circular stapler under a direct view created by the ENDOCAMELEON. Gastric Cancer. 16(4). 609–614. 13 indexed citations
20.
Fujikawa, Hirohito, Tsutomu Hayashi, Keita Fujii, et al.. (2010). . Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 35(1). 45–50. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026